Sulo, Teresita R.

HRN: 01-59-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/25/2025
10/02/2025
IV
500mg
Q8
Acute Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines